

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.18757184 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.18757184 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.81646491 |
| 4 | actin-mediated cell contraction (GO:0070252) | 6.80520580 |
| 5 | skeletal muscle contraction (GO:0003009) | 6.18737467 |
| 6 | myofibril assembly (GO:0030239) | 5.98751280 |
| 7 | sarcomere organization (GO:0045214) | 5.95009001 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 5.67936911 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.59064984 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.57168564 |
| 11 | regulation of relaxation of muscle (GO:1901077) | 5.35127508 |
| 12 | actin filament-based movement (GO:0030048) | 5.29806965 |
| 13 | striated muscle contraction (GO:0006941) | 5.23452920 |
| 14 | cardiac myofibril assembly (GO:0055003) | 5.05209353 |
| 15 | synaptic vesicle maturation (GO:0016188) | 5.04267527 |
| 16 | response to muscle activity (GO:0014850) | 4.99203175 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.95349712 |
| 18 | response to inactivity (GO:0014854) | 4.79413828 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.63962204 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.57730284 |
| 21 | locomotory exploration behavior (GO:0035641) | 4.54988237 |
| 22 | plasma membrane repair (GO:0001778) | 4.54985412 |
| 23 | actomyosin structure organization (GO:0031032) | 4.52918994 |
| 24 | cardiac muscle hypertrophy (GO:0003300) | 4.51804932 |
| 25 | skeletal muscle fiber development (GO:0048741) | 4.47669220 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.47631464 |
| 27 | cardiac muscle contraction (GO:0060048) | 4.44634733 |
| 28 | creatine metabolic process (GO:0006600) | 4.31597170 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 4.30949699 |
| 30 | skeletal muscle adaptation (GO:0043501) | 4.30476449 |
| 31 | striated muscle hypertrophy (GO:0014897) | 4.26523073 |
| 32 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.12725825 |
| 33 | muscle contraction (GO:0006936) | 4.04362355 |
| 34 | myotube cell development (GO:0014904) | 4.02882866 |
| 35 | regulation of synaptic vesicle transport (GO:1902803) | 3.98516440 |
| 36 | vocalization behavior (GO:0071625) | 3.97875165 |
| 37 | glutamate secretion (GO:0014047) | 3.96476017 |
| 38 | regulation of actin filament-based movement (GO:1903115) | 3.85968972 |
| 39 | striated muscle adaptation (GO:0014888) | 3.84972844 |
| 40 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80325677 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.76269290 |
| 42 | glycine transport (GO:0015816) | 3.75532078 |
| 43 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.72057408 |
| 44 | neurotransmitter secretion (GO:0007269) | 3.72018129 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.69859187 |
| 46 | muscle hypertrophy (GO:0014896) | 3.68740116 |
| 47 | glycogen catabolic process (GO:0005980) | 3.65573691 |
| 48 | muscle system process (GO:0003012) | 3.62751012 |
| 49 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.60757864 |
| 50 | muscle hypertrophy in response to stress (GO:0003299) | 3.60757864 |
| 51 | cardiac muscle adaptation (GO:0014887) | 3.60757864 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.60657158 |
| 53 | adult heart development (GO:0007512) | 3.58896590 |
| 54 | NADH metabolic process (GO:0006734) | 3.57317362 |
| 55 | activation of protein kinase A activity (GO:0034199) | 3.56633424 |
| 56 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.56388189 |
| 57 | muscle cell cellular homeostasis (GO:0046716) | 3.53720613 |
| 58 | myoblast fusion (GO:0007520) | 3.53146283 |
| 59 | detection of calcium ion (GO:0005513) | 3.52114114 |
| 60 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.51718564 |
| 61 | carnitine shuttle (GO:0006853) | 3.48165536 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.45119899 |
| 63 | neuron cell-cell adhesion (GO:0007158) | 3.44243875 |
| 64 | glucan catabolic process (GO:0009251) | 3.41266521 |
| 65 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.41089918 |
| 66 | dendritic spine morphogenesis (GO:0060997) | 3.38092102 |
| 67 | protein localization to synapse (GO:0035418) | 3.37040471 |
| 68 | layer formation in cerebral cortex (GO:0021819) | 3.35155192 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.34938208 |
| 70 | muscle fiber development (GO:0048747) | 3.31274210 |
| 71 | exploration behavior (GO:0035640) | 3.29974979 |
| 72 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.29269695 |
| 73 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.28465665 |
| 74 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.26759128 |
| 75 | cellular polysaccharide catabolic process (GO:0044247) | 3.26019173 |
| 76 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.24612871 |
| 77 | muscle organ development (GO:0007517) | 3.22837462 |
| 78 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.21815430 |
| 79 | regulation of synapse structural plasticity (GO:0051823) | 3.21556195 |
| 80 | muscle structure development (GO:0061061) | 3.20833421 |
| 81 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.18534885 |
| 82 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.18333681 |
| 83 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.18221513 |
| 84 | myotube differentiation (GO:0014902) | 3.17472932 |
| 85 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.17345400 |
| 86 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.17330012 |
| 87 | cardiac muscle cell development (GO:0055013) | 3.16835293 |
| 88 | insulin secretion (GO:0030073) | 3.16055610 |
| 89 | positive regulation of vesicle fusion (GO:0031340) | 3.15438918 |
| 90 | focal adhesion assembly (GO:0048041) | 3.14259111 |
| 91 | cell-substrate adherens junction assembly (GO:0007045) | 3.14259111 |
| 92 | regulation of sarcomere organization (GO:0060297) | 3.12855064 |
| 93 | chemosensory behavior (GO:0007635) | 3.12013442 |
| 94 | skeletal muscle tissue development (GO:0007519) | 3.11206418 |
| 95 | synaptic transmission, glutamatergic (GO:0035249) | 3.08344517 |
| 96 | proline transport (GO:0015824) | 3.07843130 |
| 97 | muscle adaptation (GO:0043500) | 3.07057383 |
| 98 | neurotransmitter transport (GO:0006836) | 3.06816195 |
| 99 | regulation of cell communication by electrical coupling (GO:0010649) | 3.06239069 |
| 100 | cardiac cell development (GO:0055006) | 3.06141764 |
| 101 | glucan biosynthetic process (GO:0009250) | 3.05039069 |
| 102 | glycogen biosynthetic process (GO:0005978) | 3.05039069 |
| 103 | positive regulation of membrane potential (GO:0045838) | 3.04258880 |
| 104 | cellular potassium ion homeostasis (GO:0030007) | 3.04115304 |
| 105 | gamma-aminobutyric acid transport (GO:0015812) | 3.03228239 |
| 106 | innervation (GO:0060384) | 3.00543330 |
| 107 | negative regulation of cell size (GO:0045792) | 2.99592935 |
| 108 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98827403 |
| 109 | cell communication by electrical coupling (GO:0010644) | 2.98460221 |
| 110 | regulation of myoblast differentiation (GO:0045661) | 2.98408574 |
| 111 | long-term memory (GO:0007616) | 2.96127761 |
| 112 | adherens junction assembly (GO:0034333) | 2.95890238 |
| 113 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.95619415 |
| 114 | neuromuscular process controlling posture (GO:0050884) | 2.95488360 |
| 115 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95414532 |
| 116 | striated muscle cell development (GO:0055002) | 2.91051994 |
| 117 | respiratory system process (GO:0003016) | 2.88991953 |
| 118 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.88937907 |
| 119 | glycogen metabolic process (GO:0005977) | 2.87944085 |
| 120 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87751549 |
| 121 | polysaccharide catabolic process (GO:0000272) | 2.87090507 |
| 122 | muscle tissue morphogenesis (GO:0060415) | 2.86831464 |
| 123 | Golgi transport vesicle coating (GO:0048200) | 2.86595496 |
| 124 | COPI coating of Golgi vesicle (GO:0048205) | 2.86595496 |
| 125 | suckling behavior (GO:0001967) | 2.86437061 |
| 126 | dendrite morphogenesis (GO:0048813) | 2.85702935 |
| 127 | neuron-neuron synaptic transmission (GO:0007270) | 2.85240155 |
| 128 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.85104125 |
| 129 | positive regulation of myotube differentiation (GO:0010831) | 2.85073172 |
| 130 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84226664 |
| 131 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.83436139 |
| 132 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.82439080 |
| 133 | sodium ion export (GO:0071436) | 2.82204601 |
| 134 | striated muscle atrophy (GO:0014891) | 2.81972334 |
| 135 | glucan metabolic process (GO:0044042) | 2.81540641 |
| 136 | cellular glucan metabolic process (GO:0006073) | 2.81540641 |
| 137 | cellular response to glucagon stimulus (GO:0071377) | 2.81345501 |
| 138 | regulation of neurotransmitter secretion (GO:0046928) | 2.80355767 |
| 139 | membrane depolarization during action potential (GO:0086010) | 2.80006491 |
| 140 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.79133473 |
| 141 | peptidyl-lysine dimethylation (GO:0018027) | 2.78828061 |
| 142 | regulation of striated muscle contraction (GO:0006942) | 2.78768261 |
| 143 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78600403 |
| 144 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.77901805 |
| 145 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.75901693 |
| 146 | glutamate receptor signaling pathway (GO:0007215) | 2.75653937 |
| 147 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.75186276 |
| 148 | regulation of the force of heart contraction (GO:0002026) | 2.74831106 |
| 149 | response to epinephrine (GO:0071871) | 2.74765526 |
| 150 | positive regulation of insulin secretion (GO:0032024) | 2.74521146 |
| 151 | regulation of ARF protein signal transduction (GO:0032012) | 2.74450318 |
| 152 | signal release (GO:0023061) | 2.74432901 |
| 153 | potassium ion import (GO:0010107) | 2.71996323 |
| 154 | vesicle transport along microtubule (GO:0047496) | 2.71731399 |
| 155 | neuron recognition (GO:0008038) | 2.71340863 |
| 156 | gluconeogenesis (GO:0006094) | 2.68312056 |
| 157 | regulation of myotube differentiation (GO:0010830) | 2.67966739 |
| 158 | regulation of neurotransmitter levels (GO:0001505) | 2.67900738 |
| 159 | regulation of postsynaptic membrane potential (GO:0060078) | 2.67836458 |
| 160 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.67711698 |
| 161 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.67589509 |
| 162 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.67589509 |
| 163 | 2-oxoglutarate metabolic process (GO:0006103) | 2.67559141 |
| 164 | transmission of nerve impulse (GO:0019226) | 2.66720643 |
| 165 | membrane repolarization during action potential (GO:0086011) | 2.66615974 |
| 166 | neuromuscular junction development (GO:0007528) | 2.66205197 |
| 167 | synaptic vesicle endocytosis (GO:0048488) | 2.65907892 |
| 168 | postsynaptic membrane organization (GO:0001941) | 2.65682908 |
| 169 | positive regulation of exocytosis (GO:0045921) | 2.65488698 |
| 170 | protein targeting to plasma membrane (GO:0072661) | 2.65416828 |
| 171 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.65372535 |
| 172 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.65058568 |
| 173 | neuronal ion channel clustering (GO:0045161) | 2.63773311 |
| 174 | response to pheromone (GO:0019236) | 2.63763593 |
| 175 | muscle cell development (GO:0055001) | 2.63578496 |
| 176 | regulation of exocytosis (GO:0017157) | 2.63133008 |
| 177 | mechanosensory behavior (GO:0007638) | 2.62985554 |
| 178 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.61263450 |
| 179 | regulation of skeletal muscle fiber development (GO:0048742) | 2.59994329 |
| 180 | membrane repolarization (GO:0086009) | 2.59722057 |
| 181 | peptide hormone processing (GO:0016486) | 2.58651301 |
| 182 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.58637768 |
| 183 | regulation of insulin secretion (GO:0050796) | 2.58359036 |
| 184 | neuromuscular process controlling balance (GO:0050885) | 2.58148680 |
| 185 | regulation of synaptic plasticity (GO:0048167) | 2.57604224 |
| 186 | peptide hormone secretion (GO:0030072) | 2.57276533 |
| 187 | muscle cell fate commitment (GO:0042693) | 2.56429526 |
| 188 | carnitine transmembrane transport (GO:1902603) | 2.56262490 |
| 189 | fatty acid transmembrane transport (GO:1902001) | 2.55496571 |
| 190 | membrane hyperpolarization (GO:0060081) | 2.55430074 |
| 191 | dendritic spine organization (GO:0097061) | 2.55048425 |
| 192 | auditory behavior (GO:0031223) | 2.54824939 |
| 193 | potassium ion homeostasis (GO:0055075) | 2.54720875 |
| 194 | regulation of neurotransmitter transport (GO:0051588) | 2.54484486 |
| 195 | positive regulation of potassium ion transport (GO:0043268) | 2.53056345 |
| 196 | long-term synaptic potentiation (GO:0060291) | 2.52936706 |
| 197 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.51940484 |
| 198 | organelle transport along microtubule (GO:0072384) | 2.51418385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.00341988 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.97307400 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85599779 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82275820 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81871382 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68628683 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50009231 |
| 8 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49227992 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47769260 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47413071 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44503594 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41400415 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40556093 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40556093 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40234341 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40109513 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39553641 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32878427 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.26715156 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26584764 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.26221962 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.25384738 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.22890387 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19563708 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17403047 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15901539 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13283070 |
| 28 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.09326536 |
| 29 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.09326536 |
| 30 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.07686643 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04037419 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01193354 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99795830 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.98948111 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96516882 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.92525797 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.89594875 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.84590835 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84017491 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81533360 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80982934 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75364288 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74647354 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70404606 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70390619 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69765469 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65406595 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.62851497 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.58440627 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58362828 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.56583309 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56234738 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.54595169 |
| 54 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.54332686 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52240193 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51389551 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50455420 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49494797 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48650519 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48280244 |
| 61 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.46628898 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45368467 |
| 63 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.44607358 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43359094 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42094806 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40490173 |
| 67 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39662206 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39610278 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38862354 |
| 70 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.38255610 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37292202 |
| 72 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36627104 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36523870 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.34036296 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32886365 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31903552 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31398044 |
| 78 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31095588 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30903277 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29511407 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26972132 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26781186 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25725663 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25179314 |
| 85 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25058092 |
| 86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25004463 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24785744 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 1.24169573 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24075635 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22651584 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22546437 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22114839 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22101193 |
| 94 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21956588 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19544692 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19189784 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18905826 |
| 98 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18371075 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17945237 |
| 100 | MYC_22102868_ChIP-Seq_BL_Human | 1.17712368 |
| 101 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16016255 |
| 102 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.15362919 |
| 103 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13808855 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13418271 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12520060 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.11865467 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11746721 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11429072 |
| 109 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11166426 |
| 110 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09406577 |
| 111 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09260869 |
| 112 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08936005 |
| 113 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.08811301 |
| 114 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07074854 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07073165 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06966410 |
| 117 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06872486 |
| 118 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06853990 |
| 119 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06112507 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05949272 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05878911 |
| 122 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05721835 |
| 123 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05386647 |
| 124 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04679541 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04595576 |
| 126 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04418153 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04350226 |
| 128 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.04128346 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04015704 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03935134 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02066190 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01970986 |
| 133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00473918 |
| 134 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00116209 |
| 135 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00043159 |
| 136 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99618935 |
| 137 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.98642806 |
| 138 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98637796 |
| 139 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98223195 |
| 140 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98045023 |
| 141 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97951932 |
| 142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97682014 |
| 143 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97538774 |
| 144 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97275260 |
| 145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97200303 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97012254 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96346655 |
| 148 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95911896 |
| 149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94798775 |
| 150 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94769268 |
| 151 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94303757 |
| 152 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93625116 |
| 153 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92277486 |
| 154 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91554261 |
| 155 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90966890 |
| 156 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89722359 |
| 157 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88923779 |
| 158 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88646378 |
| 159 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87675943 |
| 160 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87281141 |
| 161 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86070185 |
| 162 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85506183 |
| 163 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85260479 |
| 164 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84591867 |
| 165 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83168474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.31759754 |
| 2 | MP0000749_muscle_degeneration | 5.18720204 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.67512957 |
| 4 | MP0004270_analgesia | 3.78759334 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.49683699 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.22443504 |
| 7 | MP0004087_abnormal_muscle_fiber | 3.19464210 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.12742250 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.07871981 |
| 10 | MP0003880_abnormal_central_pattern | 2.99142713 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.95961450 |
| 12 | MP0002269_muscular_atrophy | 2.90536987 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.87161632 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.86267788 |
| 15 | MP0005451_abnormal_body_composition | 2.80616165 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.77904372 |
| 17 | MP0005369_muscle_phenotype | 2.72063526 |
| 18 | MP0004130_abnormal_muscle_cell | 2.72046335 |
| 19 | MP0009745_abnormal_behavioral_response | 2.56264241 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.51889289 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.45355241 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 2.44573254 |
| 23 | MP0002064_seizures | 2.44156348 |
| 24 | MP0009046_muscle_twitch | 2.43644348 |
| 25 | MP0004084_abnormal_cardiac_muscle | 2.43006105 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.42972062 |
| 27 | MP0000733_abnormal_muscle_development | 2.32961303 |
| 28 | MP0005620_abnormal_muscle_contractility | 2.30007467 |
| 29 | MP0003122_maternal_imprinting | 2.25628223 |
| 30 | MP0005330_cardiomyopathy | 2.24350405 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 2.20881634 |
| 32 | MP0003183_abnormal_peptide_metabolism | 2.16783526 |
| 33 | MP0003283_abnormal_digestive_organ | 2.15011226 |
| 34 | MP0005423_abnormal_somatic_nervous | 2.14154230 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 2.13931777 |
| 36 | MP0004043_abnormal_pH_regulation | 2.13681801 |
| 37 | MP0002272_abnormal_nervous_system | 2.13255334 |
| 38 | MP0001968_abnormal_touch/_nociception | 2.02131749 |
| 39 | MP0002108_abnormal_muscle_morphology | 2.00004272 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.90593238 |
| 41 | MP0001486_abnormal_startle_reflex | 1.89328702 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.85659187 |
| 43 | MP0010630_abnormal_cardiac_muscle | 1.82499452 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.79387388 |
| 45 | MP0004510_myositis | 1.79007892 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.77541358 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.73318740 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.71019478 |
| 49 | MP0001970_abnormal_pain_threshold | 1.69804203 |
| 50 | MP0003787_abnormal_imprinting | 1.68998237 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 1.67908618 |
| 52 | MP0006138_congestive_heart_failure | 1.67157229 |
| 53 | MP0002972_abnormal_cardiac_muscle | 1.66403288 |
| 54 | MP0008569_lethality_at_weaning | 1.63878780 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.63466726 |
| 56 | MP0002184_abnormal_innervation | 1.60757025 |
| 57 | MP0002822_catalepsy | 1.59799162 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.58385509 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.57763148 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.57332599 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.56563014 |
| 62 | MP0003879_abnormal_hair_cell | 1.56009616 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.55611511 |
| 64 | MP0001944_abnormal_pancreas_morphology | 1.52899800 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.52209029 |
| 66 | MP0004858_abnormal_nervous_system | 1.50160923 |
| 67 | MP0001440_abnormal_grooming_behavior | 1.48143319 |
| 68 | MP0000955_abnormal_spinal_cord | 1.43441206 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.41357037 |
| 70 | MP0003195_calcinosis | 1.40448976 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.38751600 |
| 72 | MP0004811_abnormal_neuron_physiology | 1.38337654 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.37738553 |
| 74 | MP0005386_behavior/neurological_phenoty | 1.37505003 |
| 75 | MP0004924_abnormal_behavior | 1.37505003 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34179044 |
| 77 | MP0004885_abnormal_endolymph | 1.33958912 |
| 78 | MP0000778_abnormal_nervous_system | 1.33600574 |
| 79 | MP0002736_abnormal_nociception_after | 1.29977796 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.29632734 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 1.28773427 |
| 82 | MP0006276_abnormal_autonomic_nervous | 1.28367353 |
| 83 | MP0003329_amyloid_beta_deposits | 1.24490306 |
| 84 | MP0001661_extended_life_span | 1.22052036 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 1.21745537 |
| 86 | MP0002882_abnormal_neuron_morphology | 1.21697354 |
| 87 | MP0000751_myopathy | 1.21066876 |
| 88 | MP0004484_altered_response_of | 1.20698476 |
| 89 | MP0000678_abnormal_parathyroid_gland | 1.20123755 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.19436274 |
| 91 | MP0003633_abnormal_nervous_system | 1.18552497 |
| 92 | MP0002234_abnormal_pharynx_morphology | 1.16056323 |
| 93 | MP0001544_abnormal_cardiovascular_syste | 1.15935203 |
| 94 | MP0005385_cardiovascular_system_phenoty | 1.15935203 |
| 95 | MP0001984_abnormal_olfaction | 1.15102202 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 1.14028746 |
| 97 | MP0005409_darkened_coat_color | 1.12611033 |
| 98 | MP0003172_abnormal_lysosome_physiology | 1.09900291 |
| 99 | MP0010030_abnormal_orbit_morphology | 1.09007743 |
| 100 | MP0001765_abnormal_ion_homeostasis | 1.07931988 |
| 101 | MP0005666_abnormal_adipose_tissue | 1.06039581 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 1.05132905 |
| 103 | MP0002163_abnormal_gland_morphology | 1.03871318 |
| 104 | MP0005535_abnormal_body_temperature | 0.98609001 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.97492125 |
| 106 | MP0009672_abnormal_birth_weight | 0.97088931 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.96853952 |
| 108 | MP0004233_abnormal_muscle_weight | 0.95830994 |
| 109 | MP0005670_abnormal_white_adipose | 0.95392013 |
| 110 | MP0002229_neurodegeneration | 0.95138386 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.93461182 |
| 112 | MP0002971_abnormal_brown_adipose | 0.93412138 |
| 113 | MP0005266_abnormal_metabolism | 0.91003248 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.90542063 |
| 115 | MP0001529_abnormal_vocalization | 0.90531678 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.88602620 |
| 117 | MP0004142_abnormal_muscle_tone | 0.87503051 |
| 118 | MP0003634_abnormal_glial_cell | 0.86676035 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.86021501 |
| 120 | MP0004272_abnormal_basement_membrane | 0.85427113 |
| 121 | MP0002152_abnormal_brain_morphology | 0.84797449 |
| 122 | MP0004085_abnormal_heartbeat | 0.84664924 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.84196594 |
| 124 | MP0003631_nervous_system_phenotype | 0.82302245 |
| 125 | MP0003959_abnormal_lean_body | 0.81388965 |
| 126 | MP0004134_abnormal_chest_morphology | 0.81208206 |
| 127 | MP0000266_abnormal_heart_morphology | 0.79386690 |
| 128 | MP0000747_muscle_weakness | 0.76284324 |
| 129 | MP0003953_abnormal_hormone_level | 0.75959102 |
| 130 | MP0001348_abnormal_lacrimal_gland | 0.75495974 |
| 131 | MP0004147_increased_porphyrin_level | 0.74934741 |
| 132 | MP0009250_abnormal_appendicular_skeleto | 0.73876967 |
| 133 | MP0000569_abnormal_digit_pigmentation | 0.72988698 |
| 134 | MP0003045_fibrosis | 0.72858782 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.72465640 |
| 136 | MP0001905_abnormal_dopamine_level | 0.72416398 |
| 137 | MP0006292_abnormal_olfactory_placode | 0.71783291 |
| 138 | MP0001849_ear_inflammation | 0.71659916 |
| 139 | MP0001188_hyperpigmentation | 0.71642302 |
| 140 | MP0005253_abnormal_eye_physiology | 0.70713577 |
| 141 | MP0001485_abnormal_pinna_reflex | 0.70186170 |
| 142 | MP0009703_decreased_birth_body | 0.69807722 |
| 143 | MP0003121_genomic_imprinting | 0.68641564 |
| 144 | MP0002090_abnormal_vision | 0.68397832 |
| 145 | MP0002114_abnormal_axial_skeleton | 0.67517481 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.67229047 |
| 147 | MP0002751_abnormal_autonomic_nervous | 0.66994815 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.66495072 |
| 149 | MP0000462_abnormal_digestive_system | 0.66313122 |
| 150 | MP0003385_abnormal_body_wall | 0.65914216 |
| 151 | MP0008438_abnormal_cutaneous_collagen | 0.65461195 |
| 152 | MP0002249_abnormal_larynx_morphology | 0.61886561 |
| 153 | MP0004197_abnormal_fetal_growth/weight/ | 0.61385202 |
| 154 | MP0000428_abnormal_craniofacial_morphol | 0.61078000 |
| 155 | MP0003948_abnormal_gas_homeostasis | 0.59553191 |
| 156 | MP0008775_abnormal_heart_ventricle | 0.57815057 |
| 157 | MP0008770_decreased_survivor_rate | 0.56473760 |
| 158 | MP0000534_abnormal_ureter_morphology | 0.56024195 |
| 159 | MP0005248_abnormal_Harderian_gland | 0.55381516 |
| 160 | MP0006036_abnormal_mitochondrial_physio | 0.55278253 |
| 161 | MP0003828_pulmonary_edema | 0.55107046 |
| 162 | MP0005083_abnormal_biliary_tract | 0.54562958 |
| 163 | MP0002081_perinatal_lethality | 0.51800955 |
| 164 | MP0002128_abnormal_blood_circulation | 0.51468660 |
| 165 | MP0000762_abnormal_tongue_morphology | 0.51145616 |
| 166 | MP0001346_abnormal_lacrimal_gland | 0.50768400 |
| 167 | MP0001943_abnormal_respiration | 0.48977534 |
| 168 | MP0010234_abnormal_vibrissa_follicle | 0.48597303 |
| 169 | MP0005187_abnormal_penis_morphology | 0.47018590 |
| 170 | MP0002089_abnormal_postnatal_growth/wei | 0.45808318 |
| 171 | MP0003935_abnormal_craniofacial_develop | 0.45680955 |
| 172 | MP0003091_abnormal_cell_migration | 0.43191920 |
| 173 | MP0002697_abnormal_eye_size | 0.41916077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.95838532 |
| 2 | Nemaline bodies (HP:0003798) | 8.87487787 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.84400674 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.11976273 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.88881814 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 5.60498206 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.54045953 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.37962502 |
| 9 | Myopathic facies (HP:0002058) | 5.11642660 |
| 10 | EMG: myopathic abnormalities (HP:0003458) | 4.93503147 |
| 11 | Focal motor seizures (HP:0011153) | 4.88266313 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.72060108 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.67193037 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 4.50723438 |
| 15 | Difficulty running (HP:0009046) | 4.44543923 |
| 16 | Distal arthrogryposis (HP:0005684) | 4.39212998 |
| 17 | Visual hallucinations (HP:0002367) | 4.37597332 |
| 18 | Increased connective tissue (HP:0009025) | 4.28941881 |
| 19 | Muscle fiber splitting (HP:0003555) | 4.25436042 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.14355474 |
| 21 | Myokymia (HP:0002411) | 4.05393096 |
| 22 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.05343912 |
| 23 | Myoglobinuria (HP:0002913) | 4.02916733 |
| 24 | Rimmed vacuoles (HP:0003805) | 3.93086679 |
| 25 | Increased variability in muscle fiber diameter (HP:0003557) | 3.85997136 |
| 26 | Neck muscle weakness (HP:0000467) | 3.82223213 |
| 27 | Round ear (HP:0100830) | 3.80158698 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.78059488 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.77624445 |
| 30 | Agitation (HP:0000713) | 3.72387115 |
| 31 | Focal seizures (HP:0007359) | 3.68603426 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.63018354 |
| 33 | Subaortic stenosis (HP:0001682) | 3.63018354 |
| 34 | Frequent falls (HP:0002359) | 3.49791593 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 3.49476858 |
| 36 | Pheochromocytoma (HP:0002666) | 3.39297764 |
| 37 | Epileptic encephalopathy (HP:0200134) | 3.38051456 |
| 38 | Ulnar deviation of the wrist (HP:0003049) | 3.37493373 |
| 39 | Atonic seizures (HP:0010819) | 3.29243790 |
| 40 | Papilledema (HP:0001085) | 3.23410564 |
| 41 | Hypoglycemic seizures (HP:0002173) | 3.21506559 |
| 42 | Symptomatic seizures (HP:0011145) | 3.14629226 |
| 43 | Sudden death (HP:0001699) | 3.10429951 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 3.08455233 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 3.08358849 |
| 46 | Depression (HP:0000716) | 3.04946698 |
| 47 | Areflexia of lower limbs (HP:0002522) | 3.02120500 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 2.99289943 |
| 49 | Anxiety (HP:0000739) | 2.95683748 |
| 50 | Neuroendocrine neoplasm (HP:0100634) | 2.91292672 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.90540243 |
| 52 | Absence seizures (HP:0002121) | 2.89857428 |
| 53 | Spinal rigidity (HP:0003306) | 2.89747091 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.89613589 |
| 55 | EMG: neuropathic changes (HP:0003445) | 2.88134373 |
| 56 | Calcaneovalgus deformity (HP:0001848) | 2.85687028 |
| 57 | Febrile seizures (HP:0002373) | 2.85295926 |
| 58 | Increased circulating renin level (HP:0000848) | 2.84959741 |
| 59 | Generalized tonic-clonic seizures (HP:0002069) | 2.81479537 |
| 60 | Myotonia (HP:0002486) | 2.79787475 |
| 61 | Ankle clonus (HP:0011448) | 2.78896195 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.75811705 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.72774587 |
| 64 | Hypsarrhythmia (HP:0002521) | 2.69295611 |
| 65 | Action tremor (HP:0002345) | 2.67663757 |
| 66 | Muscle stiffness (HP:0003552) | 2.66105199 |
| 67 | Lower limb amyotrophy (HP:0007210) | 2.65276461 |
| 68 | Hyperparathyroidism (HP:0000843) | 2.65058538 |
| 69 | Generalized muscle weakness (HP:0003324) | 2.63233346 |
| 70 | Hypercortisolism (HP:0001578) | 2.63193401 |
| 71 | Hemiparesis (HP:0001269) | 2.62098019 |
| 72 | Scapular winging (HP:0003691) | 2.61713873 |
| 73 | Malignant hyperthermia (HP:0002047) | 2.60283842 |
| 74 | Bulbar palsy (HP:0001283) | 2.60035288 |
| 75 | Large for gestational age (HP:0001520) | 2.59933218 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.59061267 |
| 77 | Retinal atrophy (HP:0001105) | 2.58834186 |
| 78 | Dialeptic seizures (HP:0011146) | 2.58427849 |
| 79 | Ketoacidosis (HP:0001993) | 2.53214788 |
| 80 | Hyperglycemia (HP:0003074) | 2.51767472 |
| 81 | Absent phalangeal crease (HP:0006109) | 2.43407962 |
| 82 | Deformed tarsal bones (HP:0008119) | 2.41888217 |
| 83 | Limb-girdle muscle atrophy (HP:0003797) | 2.41660580 |
| 84 | Muscular dystrophy (HP:0003560) | 2.40285437 |
| 85 | Broad-based gait (HP:0002136) | 2.39104826 |
| 86 | Slender build (HP:0001533) | 2.38396092 |
| 87 | Menstrual irregularities (HP:0000858) | 2.35633950 |
| 88 | Prolonged QT interval (HP:0001657) | 2.34939022 |
| 89 | Truncal ataxia (HP:0002078) | 2.34190241 |
| 90 | Blue irides (HP:0000635) | 2.32835341 |
| 91 | Ventricular tachycardia (HP:0004756) | 2.32607307 |
| 92 | Ventricular fibrillation (HP:0001663) | 2.32591620 |
| 93 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.26776179 |
| 94 | Limb dystonia (HP:0002451) | 2.26262329 |
| 95 | Hypokalemia (HP:0002900) | 2.24450070 |
| 96 | Dilated cardiomyopathy (HP:0001644) | 2.22609287 |
| 97 | Foot dorsiflexor weakness (HP:0009027) | 2.21451363 |
| 98 | Abnormality of the foot musculature (HP:0001436) | 2.21100185 |
| 99 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.20458066 |
| 100 | Proximal amyotrophy (HP:0007126) | 2.19819470 |
| 101 | Macroorchidism (HP:0000053) | 2.19748828 |
| 102 | Decreased circulating renin level (HP:0003351) | 2.19153911 |
| 103 | Abnormal eating behavior (HP:0100738) | 2.18863516 |
| 104 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.18676536 |
| 105 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.18676536 |
| 106 | Abnormality of renin-angiotensin system (HP:0000847) | 2.16769551 |
| 107 | Poor eye contact (HP:0000817) | 2.16616827 |
| 108 | Neurofibrillary tangles (HP:0002185) | 2.15786930 |
| 109 | Shoulder girdle muscle weakness (HP:0003547) | 2.15694265 |
| 110 | Neoplasm of the heart (HP:0100544) | 2.15075350 |
| 111 | Hyperphosphatemia (HP:0002905) | 2.13041743 |
| 112 | Bundle branch block (HP:0011710) | 2.12655463 |
| 113 | Pelvic girdle muscle weakness (HP:0003749) | 2.12623641 |
| 114 | Abnormality of potassium homeostasis (HP:0011042) | 2.11688636 |
| 115 | Megalencephaly (HP:0001355) | 2.09680254 |
| 116 | Dysdiadochokinesis (HP:0002075) | 2.08598440 |
| 117 | Failure to thrive in infancy (HP:0001531) | 2.08220444 |
| 118 | Late onset (HP:0003584) | 2.07559138 |
| 119 | Gaze-evoked nystagmus (HP:0000640) | 2.07373615 |
| 120 | Impaired smooth pursuit (HP:0007772) | 2.07325057 |
| 121 | Postural instability (HP:0002172) | 2.07032949 |
| 122 | Abnormality of the calcaneus (HP:0008364) | 2.07011229 |
| 123 | Excessive salivation (HP:0003781) | 2.06608371 |
| 124 | Drooling (HP:0002307) | 2.06608371 |
| 125 | Progressive muscle weakness (HP:0003323) | 2.05341411 |
| 126 | Genetic anticipation (HP:0003743) | 2.05324020 |
| 127 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.05103614 |
| 128 | Hyperkalemia (HP:0002153) | 2.04249239 |
| 129 | Adrenal overactivity (HP:0002717) | 2.02859908 |
| 130 | Dysmetria (HP:0001310) | 2.02517955 |
| 131 | Hypoventilation (HP:0002791) | 2.02170274 |
| 132 | Abnormal social behavior (HP:0012433) | 2.01364892 |
| 133 | Impaired social interactions (HP:0000735) | 2.01364892 |
| 134 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.00819042 |
| 135 | Abnormal EKG (HP:0003115) | 1.99278054 |
| 136 | Abnormal finger flexion creases (HP:0006143) | 1.99198505 |
| 137 | Exercise-induced myalgia (HP:0003738) | 1.97721095 |
| 138 | Lipoatrophy (HP:0100578) | 1.96166846 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.95313482 |
| 140 | Postural tremor (HP:0002174) | 1.95119498 |
| 141 | Psychosis (HP:0000709) | 1.95001832 |
| 142 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.94716018 |
| 143 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.94716018 |
| 144 | Hyperventilation (HP:0002883) | 1.93868198 |
| 145 | Waddling gait (HP:0002515) | 1.93486181 |
| 146 | Limb-girdle muscle weakness (HP:0003325) | 1.92822823 |
| 147 | Spastic gait (HP:0002064) | 1.90720547 |
| 148 | Cerebral inclusion bodies (HP:0100314) | 1.90010436 |
| 149 | Metabolic alkalosis (HP:0200114) | 1.89966694 |
| 150 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.89530077 |
| 151 | Restlessness (HP:0000711) | 1.89068008 |
| 152 | Fatigable weakness (HP:0003473) | 1.88484524 |
| 153 | Abnormality of the neuromuscular junction (HP:0003398) | 1.88484524 |
| 154 | Amblyopia (HP:0000646) | 1.88209862 |
| 155 | Achilles tendon contracture (HP:0001771) | 1.86914070 |
| 156 | Hip contracture (HP:0003273) | 1.86570864 |
| 157 | Gowers sign (HP:0003391) | 1.86415553 |
| 158 | Hyperacusis (HP:0010780) | 1.85987003 |
| 159 | Progressive inability to walk (HP:0002505) | 1.85130550 |
| 160 | Hypoglycemic coma (HP:0001325) | 1.81359065 |
| 161 | Torticollis (HP:0000473) | 1.79976714 |
| 162 | Type II lissencephaly (HP:0007260) | 1.79674708 |
| 163 | Fetal akinesia sequence (HP:0001989) | 1.78917092 |
| 164 | Long clavicles (HP:0000890) | 1.78640415 |
| 165 | Bradykinesia (HP:0002067) | 1.77855374 |
| 166 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.77628557 |
| 167 | Mucopolysacchariduria (HP:0008155) | 1.74789687 |
| 168 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74789687 |
| 169 | Weak cry (HP:0001612) | 1.74569624 |
| 170 | Hemiplegia (HP:0002301) | 1.74247099 |
| 171 | Heart block (HP:0012722) | 1.74082911 |
| 172 | Polydipsia (HP:0001959) | 1.73908946 |
| 173 | Abnormal drinking behavior (HP:0030082) | 1.73908946 |
| 174 | Abnormal atrioventricular conduction (HP:0005150) | 1.73733683 |
| 175 | Diaphragmatic weakness (HP:0009113) | 1.72098928 |
| 176 | Hypomagnesemia (HP:0002917) | 1.71773082 |
| 177 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.68693020 |
| 178 | Back pain (HP:0003418) | 1.66573724 |
| 179 | Dysmetric saccades (HP:0000641) | 1.66033479 |
| 180 | Abnormality of the Achilles tendon (HP:0005109) | 1.64960715 |
| 181 | Nonprogressive disorder (HP:0003680) | 1.64135584 |
| 182 | Steppage gait (HP:0003376) | 1.63513153 |
| 183 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.53729530 |
| 184 | Metatarsus adductus (HP:0001840) | 1.53687283 |
| 185 | Abnormality of the ischium (HP:0003174) | 1.52309522 |
| 186 | Limited hip movement (HP:0008800) | 1.48995087 |
| 187 | Short palpebral fissure (HP:0012745) | 1.48165356 |
| 188 | Obstructive sleep apnea (HP:0002870) | 1.48093995 |
| 189 | Wrist flexion contracture (HP:0001239) | 1.45596843 |
| 190 | Adducted thumb (HP:0001181) | 1.43814644 |
| 191 | Hypoplastic ischia (HP:0003175) | 1.42672542 |
| 192 | Ventricular arrhythmia (HP:0004308) | 1.41648029 |
| 193 | Stridor (HP:0010307) | 1.40312602 |
| 194 | Ragged-red muscle fibers (HP:0003200) | 1.39427133 |
| 195 | Ulnar deviation of finger (HP:0009465) | 1.38066985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.19355701 |
| 2 | WNK3 | 4.17496956 |
| 3 | NTRK3 | 3.99245332 |
| 4 | MAPK15 | 3.09107172 |
| 5 | MAP3K9 | 2.93222049 |
| 6 | PRKD3 | 2.63342491 |
| 7 | MARK1 | 2.59361636 |
| 8 | INSRR | 2.53873076 |
| 9 | ICK | 2.34966601 |
| 10 | EPHA4 | 2.25713073 |
| 11 | WNK4 | 2.24489179 |
| 12 | UHMK1 | 2.19831087 |
| 13 | SIK1 | 2.12892934 |
| 14 | MAP3K4 | 2.07465818 |
| 15 | EEF2K | 2.05832113 |
| 16 | NTRK1 | 1.97653232 |
| 17 | TESK2 | 1.93574233 |
| 18 | PAK6 | 1.91682123 |
| 19 | MAP3K2 | 1.87290551 |
| 20 | DAPK2 | 1.84463245 |
| 21 | MINK1 | 1.82364346 |
| 22 | MAP2K7 | 1.72364574 |
| 23 | MAP2K3 | 1.71532403 |
| 24 | KSR2 | 1.69847032 |
| 25 | MAPK12 | 1.67708620 |
| 26 | LATS2 | 1.67680855 |
| 27 | NTRK2 | 1.61588415 |
| 28 | CAMKK1 | 1.54606075 |
| 29 | PHKG2 | 1.48133093 |
| 30 | PHKG1 | 1.48133093 |
| 31 | HIPK2 | 1.45892240 |
| 32 | CASK | 1.42577749 |
| 33 | WNK1 | 1.41550690 |
| 34 | CAMKK2 | 1.39830268 |
| 35 | CDK5 | 1.35926395 |
| 36 | TNIK | 1.34039398 |
| 37 | MAP3K1 | 1.33795338 |
| 38 | CDK12 | 1.33667460 |
| 39 | PAK3 | 1.30899718 |
| 40 | MAP2K4 | 1.26215676 |
| 41 | EPHA3 | 1.22150373 |
| 42 | STK38 | 1.21375946 |
| 43 | PRKCH | 1.19930414 |
| 44 | SGK494 | 1.15121713 |
| 45 | SGK223 | 1.15121713 |
| 46 | MAPK13 | 1.14909191 |
| 47 | GRK5 | 1.12766921 |
| 48 | MAP3K10 | 1.11891883 |
| 49 | CDC42BPA | 1.11580837 |
| 50 | MTOR | 1.05886470 |
| 51 | PIK3CG | 0.99428954 |
| 52 | MAP3K12 | 0.97091965 |
| 53 | KSR1 | 0.96855430 |
| 54 | ARAF | 0.96613100 |
| 55 | PNCK | 0.94211877 |
| 56 | PRKCG | 0.94134422 |
| 57 | TAOK3 | 0.91668429 |
| 58 | DAPK1 | 0.91110606 |
| 59 | RET | 0.90411578 |
| 60 | SGK2 | 0.86495983 |
| 61 | OXSR1 | 0.86406181 |
| 62 | PRKAA2 | 0.85490565 |
| 63 | TAOK1 | 0.84001897 |
| 64 | CDK19 | 0.83977638 |
| 65 | TRPM7 | 0.82715810 |
| 66 | SIK2 | 0.82689665 |
| 67 | SMG1 | 0.81651652 |
| 68 | MARK2 | 0.81230051 |
| 69 | CAMK2A | 0.80208488 |
| 70 | MAP3K13 | 0.78988005 |
| 71 | PINK1 | 0.78954385 |
| 72 | PRPF4B | 0.78811087 |
| 73 | STK11 | 0.77329609 |
| 74 | SGK1 | 0.77213766 |
| 75 | PKN2 | 0.76850263 |
| 76 | AKT2 | 0.75876345 |
| 77 | SGK3 | 0.75727417 |
| 78 | CAMK1 | 0.74604263 |
| 79 | PRKD2 | 0.74195947 |
| 80 | CAMK1G | 0.73444236 |
| 81 | FES | 0.72407823 |
| 82 | CAMK2D | 0.71919392 |
| 83 | FGFR4 | 0.71858619 |
| 84 | FER | 0.71364436 |
| 85 | DMPK | 0.71052109 |
| 86 | RIPK1 | 0.68537258 |
| 87 | LATS1 | 0.68276245 |
| 88 | MUSK | 0.67894802 |
| 89 | CAMK2B | 0.67772255 |
| 90 | PRKCE | 0.67323068 |
| 91 | CAMK1D | 0.67205297 |
| 92 | SCYL2 | 0.66449293 |
| 93 | PLK2 | 0.65926116 |
| 94 | DYRK1A | 0.65014174 |
| 95 | FRK | 0.60721274 |
| 96 | CCNB1 | 0.60544161 |
| 97 | ALK | 0.57311353 |
| 98 | PDGFRA | 0.57144671 |
| 99 | RIPK4 | 0.56982074 |
| 100 | MAPKAPK3 | 0.56798852 |
| 101 | MAPK4 | 0.55155176 |
| 102 | MAP2K1 | 0.54443617 |
| 103 | RPS6KL1 | 0.51688848 |
| 104 | RPS6KC1 | 0.51688848 |
| 105 | CSNK1G2 | 0.51669256 |
| 106 | NEK6 | 0.51494822 |
| 107 | RPS6KA3 | 0.51312617 |
| 108 | CDK14 | 0.51289640 |
| 109 | LMTK2 | 0.50770593 |
| 110 | RPS6KB1 | 0.50624185 |
| 111 | PTK2 | 0.50594750 |
| 112 | BRD4 | 0.48589721 |
| 113 | TYRO3 | 0.48404818 |
| 114 | MAP3K6 | 0.47057014 |
| 115 | PDPK1 | 0.46544792 |
| 116 | CDK18 | 0.46432232 |
| 117 | TAOK2 | 0.46329739 |
| 118 | CDK15 | 0.46238293 |
| 119 | FGFR3 | 0.46198531 |
| 120 | EPHB1 | 0.45817478 |
| 121 | OBSCN | 0.45268137 |
| 122 | MAPK11 | 0.45013542 |
| 123 | BCR | 0.44663139 |
| 124 | PASK | 0.42657290 |
| 125 | AKT3 | 0.42368694 |
| 126 | PRKAA1 | 0.41321242 |
| 127 | MAPK10 | 0.40969836 |
| 128 | RPS6KA2 | 0.40649523 |
| 129 | DYRK1B | 0.40224677 |
| 130 | CAMK2G | 0.40178242 |
| 131 | CAMK4 | 0.40039489 |
| 132 | MAP3K7 | 0.39692162 |
| 133 | PDK1 | 0.39497694 |
| 134 | TRIB3 | 0.38448154 |
| 135 | CDK11A | 0.37845541 |
| 136 | RPS6KA1 | 0.36903814 |
| 137 | BRAF | 0.36315853 |
| 138 | PKN1 | 0.35476317 |
| 139 | MARK3 | 0.34682761 |
| 140 | ROCK1 | 0.34548471 |
| 141 | MAPK7 | 0.34174323 |
| 142 | RPS6KA6 | 0.33195986 |
| 143 | RPS6KB2 | 0.33086826 |
| 144 | IRAK2 | 0.31299223 |
| 145 | STK38L | 0.31114851 |
| 146 | PRKG1 | 0.26111007 |
| 147 | PDGFRB | 0.24291983 |
| 148 | PIK3CA | 0.22923918 |
| 149 | GSK3B | 0.21629320 |
| 150 | PTK6 | 0.21330665 |
| 151 | NEK9 | 0.20676142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Insulin secretion_Homo sapiens_hsa04911 | 2.93143481 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.90835994 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.81904506 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.50642781 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47388520 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33408048 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.32868074 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18386720 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.14848486 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.12625082 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.12483339 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12358685 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06177420 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05069956 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04956488 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.91827348 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90099903 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.84591017 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84367667 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76186348 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74105130 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.73128588 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72841736 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.69329705 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.68021687 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57841485 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.54687900 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54401278 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53085749 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.42511021 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42293870 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38818320 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37032363 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34540518 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30335761 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25603200 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.24965872 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23607427 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22587253 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20093193 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17661320 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.17108214 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15395390 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14758150 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.14619240 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14545186 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12989922 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11127891 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10744045 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.10451159 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06410907 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.05885776 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04599523 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03386151 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02119557 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01638519 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00866371 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00791829 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99035405 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98735484 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97571407 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.96580823 |
| 63 | Melanogenesis_Homo sapiens_hsa04916 | 0.95897201 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95421208 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94456958 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94224150 |
| 67 | Adherens junction_Homo sapiens_hsa04520 | 0.93551206 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92641047 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.90695466 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89956844 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89387717 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89068430 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88798307 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.86438856 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82941874 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.82665481 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81031348 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80516312 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80427175 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80323070 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.76068764 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75182402 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74298912 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71762728 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.69829865 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69294301 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68248250 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67804476 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.67640100 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66527474 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66194281 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65430988 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64230544 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63469131 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61099477 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60965367 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60742299 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60689383 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60670898 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60615202 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60013538 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.59734091 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58676382 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58563708 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57800050 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.57483770 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57429358 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57216917 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56722191 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56669399 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55611956 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.54643604 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54513463 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53825086 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53493860 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.52684818 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51764670 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51458068 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51329204 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50070837 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49853165 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49836068 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.49301869 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49300836 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48301804 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47848234 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.47261200 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.47117536 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.46501579 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46260008 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44234022 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44225235 |
| 133 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43656412 |
| 134 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42727131 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.38451423 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38256729 |
| 137 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37871655 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37288747 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36450055 |
| 140 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35455950 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.34490127 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34378014 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34156536 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33632066 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32800365 |

